Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer

NCT04871997 is registered in ClinicalTrials.gov with Qian Chu as lead sponsor.

NCT NCT04871997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer
Lead sponsor
Qian Chu
Phase
Observational
Overall status
Completed
Start date
July 12, 2019
Completion date
July 16, 2022
Enrollment
373 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc